Rebecca Mazahreh

4PUBLICATIONS
67CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
PF-08046876, a differentiated integrin beta-6 antibody-drug conjugate delivering a potent camptothecin payload optimized for bystander effect and reduced drug efflux.

|Apr 20, 2026
An Integrin β6-targeted antibody-drug conjugate optimized for intravesical delivery to treat non-muscle invasive bladder cancer.

|Oct 29, 2025
Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models.

David R Gruber, Elizabeth J Cummins, Weiping Zeng

|Feb 17, 2023
SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models.

Rebecca Mazahreh, Marsha L Mason, John J Gosink

Pageof 1

Frequent Collaborators

4 joint publications

Devra J Olson

2 joint publications

Lori Westendorf

2 joint publications

Nicolas H Garcia

2 joint publications

Kelly M Hensley